Published in

Wiley, Cochrane Library, 2020

DOI: 10.1002/14651858.cd001533.pub6

Wiley, Cochrane Library, 2015

DOI: 10.1002/14651858.cd001533.pub5

Wiley, Cochrane Library, 2003

DOI: 10.1002/14651858.cd001533.pub2

Links

Tools

Export citation

Search in Google Scholar

Corticosteroid therapy for nephrotic syndrome in children

Journal article published in 2002 by Susan M. Samuel, Jf F. Knight, Narelle S. Willis, Elisabeth M. Hodson, Deirdre Hahn ORCID, Jonathan C. Craig
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Corticosteroid drugs for several months after a child has nephrotic syndrome can reduce repeat episodes. Nephrotic syndrome is a condition where the kidneys leak protein from the blood into the urine. Most children who experience this syndrome have repeat episodes. When it is untreated, children can often die from infections. Corticosteroid drugs are used to reduce these infections, but the drugs can also have serious side effects. The review of trials found that using corticosteroids for several months after the first episode has an increasing ability to reduce the risk of relapses, without an increase in serious side effects.